Asia Pacific Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others). By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Inhalation Capsules Market would witness market growth of 6.7% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $101.8 Million by 2031. The Japan market is registering a CAGR of 6% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.3% during (2024 - 2031).

Inhalation capsules come in various forms, including single-dose capsules and multi-dose reservoir systems. They are often used with specialized inhalation devices that help control the airflow and ensure proper dispersion of the medication. These devices may include breath-actuated mechanisms, dose counters, and other features to enhance ease of use and patient adherence. Rising technological advancements, an increase in the prevalence of respiratory diseases, rising demand for easy drug delivery methods, and the expanding utilization of inhalation therapies have all contributed to the substantial growth of the inhalation capsules market in recent years.

Additionally, increased awareness of respiratory health and disease management prompts individuals to seek appropriate treatments. Healthcare campaigns, educational programs, and advocacy efforts emphasize the importance of early detection, proper medication adherence, and lifestyle modifications. As a result, more patients are likely to opt for inhalation therapies delivered via capsules to manage their respiratory conditions effectively.

Asia-Pacific is experiencing an increase in the prevalence of chronic obstructive pulmonary disease, which is primarily attributable to smoking, air pollution, and an aging population. Countries like China, India, and Indonesia are particularly affected, as they have high levels of air pollution and a large population of smokers. Thus, the region presents lucrative growth opportunities for the market.

Free Valuable Insights: The Global Inhalation Capsules Market is Predict to reach USD 1.4 Billion by 2031, at a CAGR of 5.9%

Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Cipla Limited
• Novartis AG
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Lonza Group Ltd. (Capsugel)
• Chiesi Farmaceutici S.p.A
• Vectura Group Plc (Philip Morris International, Inc.)
• Elpen S.A.
• Healthcaps India Ltd.
• Qualicaps Co., LTD. (Roquette Freres SA)

Asia Pacific Inhalation Capsules Market Report Segmentation

By Type

• Gelatin Capsules
• Hypromellose Capsules

By Application

• Asthma Treatment
• COPD Management
• Others

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Inhalation Capsules Market, by Type
1.4.2 Asia Pacific Inhalation Capsules Market, by Application
1.4.3 Asia Pacific Inhalation Capsules Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5. Asia Pacific Inhalation Capsules Market by Type
5.1 Asia Pacific Gelatin Capsules Market by Country
5.2 Asia Pacific Hypromellose Capsules Market by Country

Chapter 6. Asia Pacific Inhalation Capsules Market by Application
6.1 Asia Pacific Asthma Treatment Market by Country
6.2 Asia Pacific COPD Management Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Inhalation Capsules Market by Country
7.1 China Inhalation Capsules Market
7.1.1 China Inhalation Capsules Market by Type
7.1.2 China Inhalation Capsules Market by Application
7.2 Japan Inhalation Capsules Market
7.2.1 Japan Inhalation Capsules Market by Type
7.2.2 Japan Inhalation Capsules Market by Application
7.3 India Inhalation Capsules Market
7.3.1 India Inhalation Capsules Market by Type
7.3.2 India Inhalation Capsules Market by Application
7.4 South Korea Inhalation Capsules Market
7.4.1 South Korea Inhalation Capsules Market by Type
7.4.2 South Korea Inhalation Capsules Market by Application
7.5 Australia Inhalation Capsules Market
7.5.1 Australia Inhalation Capsules Market by Type
7.5.2 Australia Inhalation Capsules Market by Application
7.6 Malaysia Inhalation Capsules Market
7.6.1 Malaysia Inhalation Capsules Market by Type
7.6.2 Malaysia Inhalation Capsules Market by Application
7.7 Rest of Asia Pacific Inhalation Capsules Market
7.7.1 Rest of Asia Pacific Inhalation Capsules Market by Type
7.7.2 Rest of Asia Pacific Inhalation Capsules Market by Application

Chapter 8. Company Profiles
8.1 Cipla Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Trials and Approvals:
8.2.6 SWOT Analysis
8.3 AstraZeneca PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 Boehringer Ingelheim International GmbH
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Lonza Group Ltd. (Capsugel)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Chiesi Farmaceutici S.p.A
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 Vectura Group plc (Philip Morris International, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Geographical Expansions:
8.7.6 SWOT Analysis
8.8 Elpen S.A.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Healthcaps India Ltd.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Qualicaps Co., LTD. (Roquette Freres SA)
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Gelatin Capsules Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Gelatin Capsules Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 13 Asia Pacific COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 19 China Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 20 China Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 21 China Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 22 China Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 23 China Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 24 China Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 25 Japan Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 26 Japan Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 27 Japan Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 28 Japan Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 29 Japan Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 30 Japan Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 31 India Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 32 India Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 33 India Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 34 India Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 35 India Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 36 India Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 37 South Korea Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 38 South Korea Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 39 South Korea Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 40 South Korea Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 41 South Korea Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 42 South Korea Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 43 Australia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 44 Australia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 45 Australia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 46 Australia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 47 Australia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 48 Australia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 49 Malaysia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 50 Malaysia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 51 Malaysia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 52 Malaysia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 53 Malaysia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 54 Malaysia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 55 Rest of Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 56 Rest of Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 57 Rest of Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 58 Rest of Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 59 Rest of Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 60 Rest of Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 61 Key Information – Cipla Limited
TABLE 62 Key Information – Novartis AG
TABLE 63 Key Information – AstraZeneca PLC
TABLE 64 Key Information – Boehringer Ingelheim International GmbH
TABLE 65 Key Information –Lonza Group Ltd.
TABLE 66 Key Information – Chiesi Farmaceutici S.p.A
TABLE 67 Key Information – Vectura Group plc
TABLE 68 Key Information – Elpen S.A.
TABLE 69 Key Information – Healthcaps India Ltd.
TABLE 70 Key Information – Qualicaps Co., LTD.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Inhalation Capsules Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Inhalation Capsules Market
FIG 4 Porter’s Five Forces Analysis – Inhalation capsules market
FIG 5 Asia Pacific Inhalation Capsules Market share by Type, 2023
FIG 6 Asia Pacific Inhalation Capsules Market share by Type, 2031
FIG 7 Asia Pacific Inhalation Capsules Market by Type, 2020 - 2031, USD Million
FIG 8 Asia Pacific Inhalation Capsules Market share by Application, 2023
FIG 9 Asia Pacific Inhalation Capsules Market share by Application, 2031
FIG 10 Asia Pacific Inhalation Capsules Market by Application, 2020 - 2031, USD Million
FIG 11 Asia Pacific Inhalation Capsules Market share by Country, 2023
FIG 12 Asia Pacific Inhalation Capsules Market share by Country, 2031
FIG 13 Asia Pacific Inhalation Capsules Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Cipla Limited
FIG 15 SWOT Analysis: Novartis AG
FIG 16 Recent strategies and developments: AstraZeneca PLC
FIG 17 SWOT Analysis: AstraZeneca PLC
FIG 18 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 19 Swot Analysis: Lonza Group Ltd.
FIG 20 Recent strategies and developments: Chiesi Farmaceutici S.p.A.
FIG 21 SWOT Analysis: Chiesi Farmaceutici S.p.A
FIG 22 Recent strategies and developments: Vectura Group plc
FIG 23 Swot Analysis: Vectura Group plc
FIG 24 Swot Analysis: elpen s.a.
FIG 25 Swot Analysis: Healthcaps India Ltd.
FIG 26 Swot Analysis: Qualicaps Co., LTD.